Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Down 90.0% in March

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the recipient of a large drop in short interest in March. As of March 15th, there was short interest totalling 200 shares, a drop of 90.0% from the February 29th total of 2,000 shares. Based on an average daily volume of 21,700 shares, the days-to-cover ratio is presently 0.0 days.

Invesco Nasdaq Biotechnology ETF Stock Performance

Shares of IBBQ traded down $0.10 during trading hours on Friday, reaching $22.18. The stock had a trading volume of 49,579 shares, compared to its average volume of 23,344. Invesco Nasdaq Biotechnology ETF has a 12 month low of $18.18 and a 12 month high of $23.02. The stock has a market capitalization of $23.73 million, a PE ratio of 16.48 and a beta of 0.61. The company’s 50-day moving average is $22.13 and its two-hundred day moving average is $20.85.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 22nd. Stockholders of record on Tuesday, March 19th were paid a $0.0435 dividend. This represents a $0.17 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date was Monday, March 18th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of IBBQ. UBS Group AG raised its position in shares of Invesco Nasdaq Biotechnology ETF by 259.3% in the 1st quarter. UBS Group AG now owns 1,254 shares of the company’s stock worth $26,000 after acquiring an additional 905 shares in the last quarter. Royal Bank of Canada purchased a new position in shares of Invesco Nasdaq Biotechnology ETF in the 1st quarter worth approximately $1,940,000. Bank of America Corp DE boosted its stake in shares of Invesco Nasdaq Biotechnology ETF by 26.6% in the 4th quarter. Bank of America Corp DE now owns 17,931 shares of the company’s stock worth $378,000 after buying an additional 3,765 shares during the last quarter. Partners Capital Investment Group LLP raised its holdings in shares of Invesco Nasdaq Biotechnology ETF by 100.4% in the 2nd quarter. Partners Capital Investment Group LLP now owns 25,717 shares of the company’s stock worth $525,000 after purchasing an additional 12,887 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Invesco Nasdaq Biotechnology ETF by 66.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 27,946 shares of the company’s stock worth $571,000 after purchasing an additional 11,122 shares during the period.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.